PEGVISOMANT for Gigantism: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 252 adverse event reports in the FDA FAERS database where PEGVISOMANT was used for Gigantism.
Most Reported Side Effects for PEGVISOMANT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 460 | 15.3% | 27 | 64 |
| Drug ineffective | 328 | 10.9% | 2 | 32 |
| Insulin-like growth factor increased | 320 | 10.6% | 2 | 43 |
| Product dose omission issue | 255 | 8.5% | 2 | 36 |
| Headache | 244 | 8.1% | 1 | 41 |
| Fatigue | 224 | 7.4% | 6 | 38 |
| Arthralgia | 184 | 6.1% | 1 | 31 |
| Death | 162 | 5.4% | 162 | 11 |
| Injection site pain | 161 | 5.3% | 1 | 23 |
| Product use issue | 158 | 5.2% | 11 | 52 |
| Diarrhoea | 151 | 5.0% | 1 | 39 |
| Nausea | 142 | 4.7% | 0 | 45 |
| Pain | 121 | 4.0% | 0 | 22 |
| Malaise | 114 | 3.8% | 3 | 23 |
| Needle issue | 110 | 3.7% | 0 | 18 |
Other Indications for PEGVISOMANT
Acromegaly (1,911)
Pituitary tumour (82)
Product used for unknown indication (73)
Pituitary tumour benign (48)
Insulin-like growth factor increased (46)
Hypothalamo-pituitary disorder (41)
Neoplasm (27)
Blood growth hormone increased (21)
Brain neoplasm (20)
Insulin-like growth factor abnormal (20)